The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
Summary
- Conditions
- Raynaud Phenomena
- Systemic Sclerosis
- Type
- Interventional
- Phase
- Early Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Systemic sclerosis is a disease with a high burden caused by morbidity and increased mortality. To date a cure for SSc is not available. In this trial, patients are treated very early in the disease which could change the long term outcome of SSc in these patients. In daily practice, patients so ear...
Systemic sclerosis is a disease with a high burden caused by morbidity and increased mortality. To date a cure for SSc is not available. In this trial, patients are treated very early in the disease which could change the long term outcome of SSc in these patients. In daily practice, patients so early in the disease course are not treated although they might be at risk for early escalation and internal organ involvement, reducing their prognosis. A trial to investigate the efficacy of a relative save, inexpensive and easy accessible treatment will provide us with the opportunity to change the disease course and reducing the disease burden of a portion of the SSc patients
Tracking Information
- NCT #
- NCT03059979
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Madelon Vonk, Dr. Radboud University
Get Well Soon